slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
77,6 TWD | 0,00% | +1,31% | -3,48% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cancer Drugs
44,1
%
| 2 970 | 58,7 % | 2 430 | 44,1 % | -18,17% |
Anti-infective Drugs
18,4
%
| - | - | 1 013 | 18,4 % | - |
Invest
14,8
%
| - | - | 814 | 14,8 % | - |
Export Sales and OEM
14,5
%
| - | - | 797 | 14,5 % | - |
Medical Insurance
7,0
%
| 179 | 3,5 % | 386 | 7,0 % | +115,77% |
Other
1,2
%
| 283 | 5,6 % | 65 | 1,2 % | -76,87% |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Taiwan
87,9
%
| 4 596 | 90,8 % | 4 841 | 87,9 % | +5,33% |
Other Countries
7,2
%
| 466 | 9,2 % | 399 | 7,2 % | -14,37% |
America
4,8
%
| - | - | 266 | 4,8 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sara Hou
CEO | Chief Executive Officer | - | 18-04-22 |
Guo Jiang Zhang
DFI | Director of Finance/CFO | - | 31-12-15 |
Shu Fen Huang
CMP | Compliance Officer | - | 18-04-22 |
Nai Wei Liu
ADM | Chief Administrative Officer | - | 04-12-18 |
Shih-Chou Chen
IRC | Investor Relations Contact | - | - |
Jung Liang Kao
AUD | Comptroller/Controller/Auditor | - | 26-03-21 |
Wen Po Huang
PRN | Corporate Officer/Principal | - | 04-11-21 |
Jen-Yang Chang
HRO | Human Resources Officer | - | 01-05-19 |
Shu-Wen Wang
AUD | Comptroller/Controller/Auditor | - | 13-08-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Wen Hua Chang
BRD | Director/Board Member | - | 24-07-95 |
Hsiu Chi Chang
BRD | Director/Board Member | - | 24-06-16 |
Tzu Chiang Yang
BRD | Director/Board Member | 68 | 24-06-16 |
Tien Fu Lin
BRD | Director/Board Member | - | 24-06-16 |
Chuan Lin
CHM | Chairman | 72 | 22-11-18 |
Tui Tsai
BRD | Director/Board Member | - | 24-06-16 |
Ming-Ling Hsueh
BRD | Director/Board Member | 68 | 24-06-16 |
Ying Ying Liao
BRD | Director/Board Member | - | 24-06-16 |
Carl Hsiao
BRD | Director/Board Member | - | 26-03-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 248 650 000 | 200 715 959 ( 80,72 %) | 0 | 80,72 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,48% | 598 mln. | |
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
-3,40% | 157 mld. |
- Beurs
- Aandelen
- Koers 4105
- Onderneming TTY Biopharm Company Limited